Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 10126 - 10150 of 13062 in total
Experimental
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Experimental
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Experimental
Matched Iupac: … 6-amino-1-methyl-2-oxo-2,3-dihydropyrimidin-1-ium …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Gallium maltolate is Titan’s novel oral agent in development for the potential treatment of chronic bacterial infections, bone disease and cancer.
Investigational
Matched Iupac: … gallium(3+) ion tris(2-methyl-4-oxo-4H-pyran-3-olate) …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Pirodavir is an antipicornavirus agent.
Experimental
Matched Iupac: … ethyl 4-{2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy}benzoate …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Talsupram is a selective norepinephrine reuptake inhibitor (NRI). It was under research for the treatment of depression in 1960 and 1970 but it was never marketed. Talsupram presents a similar structure to citalopram.
Experimental
Matched Iupac: … [3-(3,3-dimethyl-1-phenyl-1,3-dihydro-2-benzothiophen-1-yl)propyl](methyl)amine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Creatinine has been used in trials studying the treatment of Amyotrophic Lateral Sclerosis.
Investigational
Matched Iupac: … 2-imino-1-methylimidazolidin-4-one …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Cadazolid has been used in trials studying the treatment of Clostridium Difficile Infection.
Investigational
Matched Iupac: … )-4-hydroxypiperidin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ... 1-cyclopropyl-6-fluoro-7-[4-({2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenoxy}methyl …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Basmisanil has been used in trials studying the treatment and basic science of Down Syndrome.
Investigational
Matched Iupac: … 4-(6-{[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy}pyridine-3-carbonyl)-1lambda6-thiomorpholine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Aes-103 has been used in trials studying the treatment and prevention of Hypoxia, Anemia, Sickle Cell, and Sickle Cell Disease.
Investigational
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Verdiperstat has been used in trials studying the basic science and treatment of Multiple System Atrophy (MSA).
Investigational
Matched Iupac: … 1-[2-(propan-2-yloxy)ethyl]-2-sulfanylidene-1H,2H,3H,4H,5H-pyrrolo[3,2-d]pyrimidin-4-one …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
ASP3026 has been used in trials studying the treatment of Solid Tumor, B-Cell Lymphoma, Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, and Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS.
Investigational
Matched Iupac: … N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N4-[2-(propane-2-sulfonyl)phenyl]-1,3,5 …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Pelitrexol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Iupac: … (2S)-2-[(5-{2-[(6S)-2-amino-4-oxo-3H,4H,5H,6H,7H,8H-pyrido[2,3-d]pyrimidin-6-yl]ethyl}-4-methylthiophen …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Farampator is under investigation in clinical trial NCT00113022 (Org 24448 to Treat Major Depression).
Investigational
Matched Iupac: … 5-(piperidine-1-carbonyl)-2,1,3-benzoxadiazole …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Investigational
Matched Iupac: … 2-{2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetamido}acetic acid …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Modipafant is under investigation in clinical trial NCT02569827 (Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore).
Investigational
Matched Iupac: … ethyl (4R)-4-(2-chlorophenyl)-6-methyl-2-(4-{2-methyl-1H-imidazo[4,5-c]pyridin-1-yl}phenyl)-5-[(pyridin …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Investigational
Experimental
Matched Name: … 4-Flourobenzenesulfonamide …
Matched Iupac: … 4-fluorobenzene-1-sulfonamide …
Experimental
Matched Name: … 3-Amino-4-Oxybenzyl-2-Butanone …
Matched Iupac: … (3S)-3-amino-4-(benzyloxy)butan-2-one …
Experimental
Matched Name: … 4-(Hydroxymethyl)Benzamidine …
Matched Iupac: … 4-(hydroxymethyl)benzene-1-carboximidamide …
Investigational
Matched Synonyms: … -4-yl)- ... 3-pyridazinecarboxamide, 6-((5-methyl-3-(6-methyl-3-pyridinyl)-4-isoxazolyl)methoxy)-n-(tetrahydro-2h-pyran …
Matched Iupac: … 6-{[5-methyl-3-(6-methylpyridin-3-yl)-1,2-oxazol-4-yl]methoxy}-N-(oxan-4-yl)pyridazine-3-carboxamide …
Experimental
Matched Iupac: … ethyl 4-[2-(piperidin-1-yl)acetamido]benzoate …
Experimental
Illicit
Matched Synonyms: … 2,5-dimethoxy-4-propylthiophenethylamine …
Matched Name: … 2,5-Dimethoxy-4-(n)-propylthiophenethylamine …
Matched Iupac: … 2-[2,5-dimethoxy-4-(propylsulfanyl)phenyl]ethan-1-amine …
Alferminogene tadenovec, Cardium’s lead product candidate, is being developed for the potential treatment of myocardial ischemia that gives rise to angina symptoms associated with coronary heart disease. Alferminogene tadenovec represents a new therapeutic class of biologics designed to promote angiogenesis and thereby improve blood flow following a one-time intracoronary administration...
Investigational
Matched Synonyms: … Ad5FGF-4
Displaying drugs 10126 - 10150 of 13062 in total